Predictive value of monocyte to high-density lipoprotein cholesterol ratio and tumor markers in colorectal cancer and their relationship with clinicopathological characteristics

Table 6 Comparison of 202 CRC patient’s clinicopathological features stratified by MHR, CEA, CA199

Indicators	MHR		P	CEA		P	CA199		P
	≤ 0.387	> 0.387		≤ 3.61	> 3.61		≤ 12.95	> 12.95
Tumor stage
I + II	21	88	0.728	61	47	0.004	64	45	0.669
III + IV	20	73		33	60		51	42
Lymph node metastasis
Absence	20	82	0.862	59	43	0.002	60	42	0.670
Presence	21	79		36	64		55	45
Tumor size
< 5 cm	21	95	0.382	62	54	0.046	75	41	0.014
≥ 5 cm	20	66		33	53		40	46
Tumor differentiation
Senior	4	30	0.243	19	15	0.266	20	14	0.851
Middle + Low	37	131		76	92		95	73
Tumor type
Mass	15	47	0.448	36	26	0.047	32	30	0.356
Infiltration + Ulcers	26	114		59	81		83	57

The P value was calculated by chi square test. The numbers in the table represent the number of samples
CA199 carbohydrate antigen 199, CEA carcinoembryonic antigen, MHR monocytes to high-density lipoprotein cholesterol ratio

ISSN: 1477-7819